Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 21, 2017; 23(11): 2012-2022
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2012
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2012
Covariates | Coefficient | Standard error | HR | 95% CI for HR | P value |
Tumor location (cardia vs others) | 0.451 | 0.202 | 1.570 | 1.057-2.333 | 0.0261 |
Tumor size (≥ 5 vs < 5 cm) | 0.723 | 0.232 | 2.060 | 1.309-3.243 | 0.0021 |
Vessel invasion (positive vs negative) | NA | NA | NA | NA | NA |
TNM stage (stage III and IV vs I and II) | 1.086 | 0.243 | 1.961 | 1.839-4.768 | 0.0001 |
CDK5 and CRM1 expression | |||||
(low/high vs high/high) | 0.568 | 0.254 | 1.765 | 1.074-2.903 | 0.0251 |
(low/low vs high/high) | 0.769 | 0.269 | 2.158 | 1.274-3.657 | 0.0041 |
Borrmann type (type early, I, II vs III, IV) | NA | NA | NA | NA | NA |
- Citation: Sun YQ, Xie JW, Xie HT, Chen PC, Zhang XL, Zheng CH, Li P, Wang JB, Lin JX, Cao LL, Huang CM, Lin Y. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer. World J Gastroenterol 2017; 23(11): 2012-2022
- URL: https://www.wjgnet.com/1007-9327/full/v23/i11/2012.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i11.2012